Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) HKSE
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In HKD
Address
Office Tower, Convention Plaza
Beijing,
China
Phone
852 3628 3911
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2843
First IPO Date
October 28, 2010
| Name | Title | Pay | Year Born |
| Guili Miao | Deputy Chief Executive Officer, Chief Investment Officer, Chief Financial Officer & Executive Director | 2.98M | 1974 |
| Weicheng Guo | Deputy Chairman & Chief Executive Officer | 3.47M | 1964 |
| Jionglong Zhang | Executive Director | 759,338 | 1962 |
| Yanling Chen | Joint Company Secretary & Executive Director | 2.09M | 1978 |
| Xianhui Meng | Deputy General Manager | 4.94M | 1964 |
| Fengsheng Che | Co-Founder & Executive Chairman | 8.1M | 1962 |
| Kin Wai Li | Joint Company Secretary | 0 | 1989 |
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China and the United States. It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions. It also provides drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. In addition, the company involved in the provision of research and development, and industrialization of innovative medicine; construction for medical project; provision of general hospital services and hospital management services; and property investment business. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.